Xue-Ling Liu
Overview
Explore the profile of Xue-Ling Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
[Mechanism of Qiwei Guibao Granules in treatment of premature ovarian failure based on metabolomics]
Mao W, Zhu X, Liu X, Xu Z, Yao Y, Liu C, et al.
Zhongguo Zhong Yao Za Zhi
. 2024 Aug;
49(14):3887-3893.
PMID: 39099362
In this study, a mouse model of premature ovarian failure(POF) was constructed by injecting D-galactose(200 mg·kg~(-1)) into the back of the neck for 6 weeks. The mice were randomly divided...
2.
Gu C, Shao J, Liu X, Wei J, Huang G, Xiao J
Int J Biol Macromol
. 2024 Jun;
273(Pt 2):133139.
PMID: 38878929
The microencapsulation of polysaturated fatty acids by spray drying remains a challenge due to their susceptibility to oxidation. In this work, antioxidant Pickering emulsions were attempted as feeds to produce...
3.
Liu X, Mao W, Zhou Z, Xu Z, Tao W, Zhu X, et al.
Zhongguo Zhong Yao Za Zhi
. 2023 Apr;
48(5):1310-1318.
PMID: 37005815
In this study, the underlying mechanism of Qiwei Guibao Granules(QWGB) in the treatment of premature ovarian fai-lure(POF) was explored by the proteomics technique. Firstly, the POF model was induced in...
4.
Chang L, Xu X, Liu X, Guo Q, Fan Y, He B, et al.
Cancer Cell Int
. 2021 Dec;
21(1):663.
PMID: 34895230
m6A (N6-methyladenosine) methylation, a well-known modification in tumour epigenetics, dynamically and reversibly fine tunes the entire process of RNA metabolism. Aberrant levels of m6A and its regulators, which can predict...
5.
Hu C, Guo X, Liu X, Liu G, Xu X, Mao Q, et al.
Zhongguo Zhong Yao Za Zhi
. 2021 Sep;
46(15):3943-3948.
PMID: 34472271
The study aims to investigate the effect of the compatibility of paeonol and paeoniflorin(hereinafter referred to as the compatibility) on the expression of myocardial proteins in rats with myocardial ischemia...
6.
Wang N, Liu X, Li L, Zuo C, Wang J, Wu P, et al.
J Magn Reson Imaging
. 2020 Oct;
53(3):722-730.
PMID: 33096586
Background: Swallow tail sign (STS) on MRI is presumed to be an imaging biomarker of nigrosome-1, which may exhibit a similar role as positron emission tomography (PET), indicating dopaminergic degeneration....
7.
Liu X, Wang B, Wang Y, Wang Y, Yang C, Tan C, et al.
Signal Transduct Target Ther
. 2019 Dec;
4:49.
PMID: 31798976
No abstract available.
8.
Liu X, Liu J, Xu Y, Zhang X, Wang Y, Qing L, et al.
Int J Cancer
. 2019 Jan;
145(3):817-829.
PMID: 30671946
The hotspot mutation H1047R in the oncogenic PIK3CA gene is frequently detected in breast cancer and enhances the enzymatic activity of PI3K to activate AKT/mTOR signaling cascade. Aberrant elevated PI3K...
9.
Liu X, Xu Y, Wang Y, Chen Y, Wang B, Wang Y, et al.
Cancer Lett
. 2018 Jul;
433:273-282.
PMID: 30003928
PI3Ks are frequently hyper-activated in breast cancer and targeting PI3Kα has exhibited promising but variable response in preclinical and clinical settings. CYH33 is a novel PI3Kα-selective inhibitor in phase I...
10.
Liu X, Ding J, Meng L
Acta Pharmacol Sin
. 2018 Apr;
39(10):1553-1558.
PMID: 29620049
Oncogene-induced cellular senescence (OIS) is a complex program that is triggered in response to aberrant activation of oncogenic signaling. Initially, OIS was thought to be a barrier to malignant transformation...